Friday, November 29, 2024
Home Authors Posts by Editor / Curator

Editor / Curator

928 POSTS 0 COMMENTS
2023 Watch List

CEO Interview: Ric Schumacher Pressure Bioscience (PBIO).

Editor / Curator -
pRESSURE bIOSCIENCE
2023 Watch List

Pressure BioSciences (PBIO) Receives $1.5M Contract for UltraShear Nanoemulsified CBD.

Editor / Curator -
2022 Watch List

Asia-Pacific: A Region of Stability Amidst Economic Uncertainty

Editor / Curator -
2020 Watch List

Hepion (HEPA) Back in the Spotlight, Gains 230% in May.

Editor / Curator -
2023 Watch List

Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical...

Editor / Curator -
2023 Watch List

Video: New Topical Drug Delivery System, NeuroDirect™

Editor / Curator -
2023 Watch List

Topical PTSD Drug Poised for Human Trials.

Editor / Curator -
Uncategorized

Ketamine and Yale University

Editor / Curator -
Zappy Zapolin, Lamar Odom, Roland Rick Perry
2023 Watch List

Adding Psycheceutical Bioscience (BWVI) $0.14 to Watch List. Ketamine.

Editor / Curator -
AI Artificial Intelligence

Khan Academy’s AI Pilot Program.

Editor / Curator -
1...161718...93Page 17 of 93

Latest article

Nine Page Summary Report on GeoVax (GOVX)

2024 Watch List Editor / Curator -
This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

2024 Watch List Editor / Curator -
Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

All News Editor / Curator -
Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.